MeSH tree: D02.241.223.601
Without his medication, my son, who has ADHD, is a boat adrift on choppy seas. He bumps around, spilling drinks and food, unable to control his limbs and impulses. He can't sit still; he won't stop talking—loudly. His emotions ...
Feb 3, 2023
0
152
There is new evidence that a 50-year-old blood pressure drug could find new purpose as a treatment to mitigate the often life-altering effects of increasingly prevalent PTSD, scientists say.
Jan 5, 2023
2
179
Individuals with long COVID, sometimes referred to as "long-haulers," experience symptoms that may persist for weeks, months, or even years after their acute viral infection. While symptoms vary widely, a common complaint ...
Dec 14, 2022
0
256
Shortages of the ADHD drug Adderall are expected to continue for months, forcing families to scramble for ways to deal with their children's attention deficit hyperactivity disorder (ADHD).
Dec 13, 2022
0
183
For decades, doctors have treated kids with attention-deficit/hyperactivity disorder (ADHD) with methylphenidate, a stimulant drug sold as Ritalin and Concerta, making it one of the most widely prescribed medications aimed ...
Dec 8, 2022
0
334
A national shortage of Adderall has people with attention deficit/hyper activity disorder scrambling to find a pharmacy that can refill their prescription.
Oct 28, 2022
0
156
Psychostimulants are commonly used as treatments of psychiatric disorders or to improve cognition, but the benefits of these drugs are not the same for everyone, as their effects vary greatly both across individuals and within ...
Sep 27, 2022
0
71
Short-term use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a first-time hospitalization for heart failure in patients with type 2 diabetes, according to research presented at ESC Congress 2022.
Aug 23, 2022
0
348
For acute renal colic, acupuncture as an adjunct to intramuscular injection of diclofenac sodium may accelerate pain relief, according to a study published online Aug. 9 in JAMA Network Open.
Aug 10, 2022
0
31
Haleon, the consumer healthcare unit spun off by British drugs giant GlaxoSmithKline, was worth around £31 billion ($36 billion) when it began trading in London on Monday.
Jul 18, 2022
0
93
